ReviewCancers2022
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer.
Martín Núñez Abad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this papercites it
ReviewCancers2022
Martín Núñez Abad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.